VCYT
VERACYTE, INC.
NASDAQ · Healthcare · Biotechnology · US
$43.80
+1.58%0
Insider buys (3m)
9
Insider sells (3m)
-$1.3M
Net value (3m)
-23.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 22, 2026 | Leite John · officer: Global Chief Commercial Off | Sale | 4,015 | $40 |
| Sep 16, 2026 | Holstein Jens · director | Sale | 5,000 | $41 |
| Sep 4, 2026 | Chambers Rebecca · officer: Chief Financial Officer | Sale | 2,477 | $43 |
| Sep 4, 2026 | Febbo Phillip G. · officer: Chief Scientific & Med Officer | Sale | 2,705 | $44 |
| Sep 4, 2026 | Leite John · officer: Global Chief Commercial Off | F-InKind | 3,961 | $45 |
| Sep 4, 2026 | Chambers Rebecca · officer: Chief Financial Officer | F-InKind | 3,603 | $45 |
| Sep 4, 2026 | Stapley Marc · director, officer: Chief Executive Officer | F-InKind | 8,782 | $45 |
| Sep 4, 2026 | McGuire Annie · officer: EVP, General Counsel | F-InKind | 3,215 | $45 |
| Sep 4, 2026 | Chambers Rebecca · officer: Chief Financial Officer | Sale | 1,175 | $44 |
| Sep 4, 2026 | Febbo Phillip G. · officer: Chief Scientific & Med Officer | Sale | 10,405 | $43 |
| Sep 4, 2026 | Wygant Jonathan · officer: VP, Chief Accounting Officer | F-InKind | 1,361 | $45 |
| Sep 4, 2026 | McGuire Annie · officer: EVP, General Counsel | Sale | 2,154 | $43 |
| Sep 4, 2026 | McGuire Annie · officer: EVP, General Counsel | Sale | 1,100 | $44 |
| Sep 4, 2026 | Febbo Phillip G. · officer: Chief Scientific & Med Officer | F-InKind | 3,639 | $45 |
| Sep 3, 2026 | Bhanji Muna · director | Sale | 1,864 | $43 |
| Jun 22, 2026 | EASTHAM KARIN · director | Sale | 3,200 | $53 |
| Jun 22, 2026 | EASTHAM KARIN · director | Sale | 529 | $54 |
| Jun 15, 2026 | Barr Eliav · director | A-Award | 5,272 | $0.00 |
| Jun 15, 2026 | Shafer David Brent · director | A-Award | 5,272 | $0.00 |
| Jun 15, 2026 | Bhanji Muna · director | A-Award | 5,272 | $0.00 |
| Jun 15, 2026 | Holstein Jens · director | A-Award | 5,272 | $0.00 |
| Jun 15, 2026 | JONES EVAN/ FA · director | A-Award | 5,272 | $0.00 |
| Jun 15, 2026 | EPSTEIN ROBERT S · director | A-Award | 5,272 | $0.00 |
| Jun 15, 2026 | EASTHAM KARIN · director | A-Award | 5,272 | $0.00 |
| Jun 15, 2026 | Miller Thomas F. · director | A-Award | 5,272 | $0.00 |
| Jun 4, 2026 | McGuire Annie · officer: EVP, General Counsel | Sale | 1,776 | $50 |
| Jun 4, 2026 | Chambers Rebecca · officer: Chief Financial Officer | Sale | 1,600 | $49 |
| Jun 4, 2026 | Chambers Rebecca · officer: Chief Financial Officer | Sale | 1,961 | $50 |
| Jun 4, 2026 | Leite John · officer: Global Chief Commercial Off | Sale | 13,975 | $50 |
| Jun 4, 2026 | McGuire Annie · officer: EVP, General Counsel | Sale | 1,400 | $49 |
Institutional positioning
13F filings over the trailing two quarters
New 128Increased 272Reduced 228Sold out 48
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 13,486,437 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 13,172,618 | May 13, 2026 |
| FMR LLC | Increased | 7,763,849 | May 15, 2026 |
| FMR LLC | Reduced | 7,702,746 | Aug 13, 2026 |
| Artisan Partners Limited Partnership | Increased | 5,538,404 | Aug 13, 2026 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | Reduced | 5,496,370 | May 13, 2026 |
| STATE STREET CORP | Increased | 5,043,590 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 4,716,191 | Aug 13, 2026 |
| STATE STREET CORP | Reduced | 4,698,128 | Sep 22, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4,444,730 | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 3,593,922 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,532,232 | May 15, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | Reduced | 3,053,818 | May 12, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 2,881,090 | May 7, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 2,826,524 | Aug 11, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 22, 2026